HeartFlow Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) for the HeartFlow Planner, a non-invasive, real-time virtual modeling tool for coronary artery disease (CAD)...
-
-
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute ST-segment elevation myocardial...
-
Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and effectiveness of its TriClip transcatheter tricuspid valve repair system for the treatment of...
-
Corindus Vascular Robotics Inc. announced that EClinicalMedicine, a clinical journal published by The Lancet, has published the results from the Telerobotic Intervention Study, the world’s first...
Technology | Atherectomy Devices | September 13, 2019
September 13, 2019 — Rex Medical L.P. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA...
News | Ventricular Assist Devices (VAD) | September 12, 2019
September 12, 2019 — CorWave announced successful completion of its first 60-day preclinical study to evaluate its...
The REDUCE LAP HF-II study will combine Corvia Medical's InterAtrial Shunt Device (IASD), pictured here, with physIQ's continuous monitoring platform to evaluate the device's efficacy in patients with heart failure. Image courtesy of Corvia Medical.
News | Heart Failure | September 12, 2019
September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a...
Sponsored Content
Pass-through status and new CPT codes are expectred to boost usage of contrast-enhanced ultrasound procedures. The individuals who appear are for illustrative purposes only. All persons depicted are models and not real patients or healthcare professionals.
Case Study | Cardiovascular Ultrasound | May 29, 2019
As part of the ...
Technology | CT Angiography (CTA) | September 12, 2019
September 12, 2019 — HeartFlow Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) for the...
News | Heart Valve Technology | September 11, 2019
September 11, 2019 — Percutaneous reduction of...
Image courtesy of Amazon.com
News | Heart Failure | September 11, 2019
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse,...
Sponsored Content
Feature | Sudden Cardiac Arrest | October 25, 2018
Pre-participation physical evaluations (PPEs) are a standard requirement for many school-aged athletes to...
News | Antiplatelet and Anticoagulation Therapies | September 10, 2019
September 10,2019 — The combination of...
News | Cath Lab | September 10, 2019
September 10, 2019 — An international randomized trial has shown that complete revascularization reduces major...
Sponsored Content
Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.
Feature | Sudden Cardiac Arrest | October 16, 2018
Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent...
News | Antiplatelet and Anticoagulation Therapies | September 09, 2019
September 9, 2019 — Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary...
News | Heart Failure | September 09, 2019
September 9, 2019 — AstraZeneca announced detailed results from the landmark Phase III DAPA-HF...
Sponsored Content
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the...
The cath lab staff UH Portage Medical Center.
Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
ESC President Barbara Casadei, M.D., DPhil, FRCP, FESC, a British Heart Foundation Professor and an honorary consultant cardiologist at the John Radcliffe Hospital in Oxford, speaks at a press conference at the 2019 ESC Congress.
Feature | ESC | September 09, 2019
September 9, 2019 — More than 33,000 health professionals gathered over five days to attend the 2019...
News | Heart Failure | September 09, 2019
September 9, 2019 — The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart...
